학술논문

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
Document Type
Article
Source
In: Vaccine. (Vaccine, 1 October 2013, 31(42):4867-4873)
Subject
Language
English
ISSN
0264410X
18732518